NM_015102.5:c.1867A>G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_015102.5(NPHP4):c.1867A>G(p.Thr623Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,613,812 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015102.5 missense
Scores
Clinical Significance
Conservation
Publications
- nephronophthisis 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Senior-Loken syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- nephronophthisis 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| NPHP4 | NM_015102.5 | c.1867A>G | p.Thr623Ala | missense_variant | Exon 15 of 30 | ENST00000378156.9 | NP_055917.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| NPHP4 | ENST00000378156.9 | c.1867A>G | p.Thr623Ala | missense_variant | Exon 15 of 30 | 1 | NM_015102.5 | ENSP00000367398.4 | ||
| NPHP4 | ENST00000378169.7 | n.*768A>G | non_coding_transcript_exon_variant | Exon 12 of 27 | 1 | ENSP00000367411.3 | ||||
| NPHP4 | ENST00000489180.6 | n.1864A>G | non_coding_transcript_exon_variant | Exon 15 of 33 | 2 | ENSP00000423747.1 | ||||
| NPHP4 | ENST00000378169.7 | n.*768A>G | 3_prime_UTR_variant | Exon 12 of 27 | 1 | ENSP00000367411.3 | 
Frequencies
GnomAD3 genomes  0.000762  AC: 116AN: 152194Hom.:  1  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.000269  AC: 67AN: 249302 AF XY:  0.000207   show subpopulations 
GnomAD4 exome  AF:  0.0000931  AC: 136AN: 1461500Hom.:  0  Cov.: 32 AF XY:  0.0000715  AC XY: 52AN XY: 727038 show subpopulations 
Age Distribution
GnomAD4 genome  0.000762  AC: 116AN: 152312Hom.:  1  Cov.: 32 AF XY:  0.000631  AC XY: 47AN XY: 74488 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:2 
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
NPHP4-related disorder    Benign:1 
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Nephronophthisis    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at